WST

West Pharmaceutical Services Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth↓ 3/10
  • Momentum↑ 5/10
West Pharmaceutical Services sales and earnings growth
WST Growth
Neutral
  • Revenue Y/Y↑ 6.25%
  • EPS Y/Y↓ 1.19%
  • FCF Y/Y↑ 69.65%
West Pharmaceutical Services gross and profit margin trends
WST Profitability
Good
  • Gross margin ↑ 35.90%
  • EPS margin↑ 16.10%
  • ROIC↑ 20.60%
West Pharmaceutical Services recent dividend growth
WST Dividends
  • Dividend yield 0.36%
  • Growth 3Y↑ 5.07%
  • Payout ratio↑ 12%
West Pharmaceutical Services net debt vs free cash flow
WST Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 1231.6

West Pharmaceutical Services stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗